| 2026-05-26 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 339,85k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 9,62 | - | - |
| 2026-05-26 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 27,12k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 9,62 | - | - |
| 2026-05-26 | Ms. Marie E. McDonaldIndependent Non-Executive Director | 23,14k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 9,62 | - | - |
| 2026-05-26 | Mr. William R. JellisonNon-Executive Director | 21,60k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 9,47 | - | - |
| 2026-05-26 | Dr. Maria RivasNon-Executive Director | 21,60k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 9,47 | - | - |
| 2026-05-26 | Mr. David N. GillNon-Executive Director | 30,05k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-03-06 | State Street Global Advisors, Inc.Società | -456,02k | 30,16k | Other Disposition | 7,54 - 10,94 | 29,54M | -1,52% |
| 2026-04-28 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 67,94k | 996,74k | Acquisto | 14,48 - 14,87 | 21,00M | 0,32% |
| 2026-04-16 | Challenger LimitedSocietà | -856,22k | 9,54M | Vendita | 11,14 | 16,91M | -4,82% |
| 2026-04-29 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 67,94k | 711,12k | Acquisto | 10,47 | 21,40M | 0,32% |
| 2026-04-15 | JPMorgan Chase & Co.Società | -1,41M | 0,00 | Other Disposition | - | 23,36M | -5,69% |
| 2026-04-15 | JPMorgan Chase & Co.Società | -125,14k | 1,35M | Vendita | 10,15 - 11,03 | 23,36M | -0,53% |
| 2026-04-15 | JPMorgan Chase & Co.Società | 320,71k | 3,19M | Acquisto | 10,24 - 10,85 | 23,36M | 1,39% |
| 2026-04-15 | JPMorgan Chase & Co.Società | -5,30M | 0,00 | Other Disposition | - | 10,98M | -32,56% |
| 2026-04-20 | JP Morgan Asset ManagementSocietà | -60,55k | 0,00 | Other Disposition | - | 225,23k | -21,19% |
| 2026-04-15 | JP Morgan Asset ManagementSocietà | 1,82k | 19,38k | Acquisto | 10,67 | 225,23k | 0,81% |
| 2026-01-04 | Challenger LimitedSocietà | -218,06k | 1,95M | Other Disposition | 8,94 | 17,76M | -1,21% |
| 2026-04-13 | Challenger LimitedSocietà | -46,00k | 508,89k | Vendita | 11,06 | 17,76M | -0,26% |
| 2026-04-14 | Highbridge Capital Management, LLCSocietà | -143,37k | 1,07M | Other Disposition | 7,47 | 71,69k | -66,67% |
| 2026-02-18 | JPMorgan Chase & Co.Società | 1,33M | 6,80M | Acquisto | 6,34 - 11,39 | 4,41M | 43,06% |
| 2026-02-18 | JPMorgan Chase & Co.Società | -14,91M | 0,00 | Other Disposition | - | 15,75M | -48,63% |
| 2026-02-25 | JPMorgan Chase & Co.Società | -2,31k | 19,74k | Vendita | 6,72 - 9,17 | 15,75M | -0,01% |
| 2026-03-05 | JPMorgan Chase & Co.Società | 581,00 | 4,13k | Acquisto | 7,11 | 15,75M | 0,00% |
| 2026-03-03 | JP Morgan Asset ManagementSocietà | -100,03k | 862,86k | Vendita | 6,96 - 8,78 | 253,04k | -28,33% |
| 2026-03-02 | JP Morgan Asset ManagementSocietà | 8,81k | 64,27k | Acquisto | 7,07 - 7,88 | 253,04k | 3,61% |
| 2026-02-18 | JPMorgan Chase & Co.Società | -6,89M | 0,00 | Other Disposition | - | 4,41M | -60,98% |
| 2026-02-18 | JPMorgan Chase & Co.Società | -2,19M | 9,59M | Vendita | 6,31 - 11,26 | 4,41M | -33,18% |
| 2026-04-08 | Citigroup Inc.Società | -1,24M | 0,00 | Other Disposition | - | 11,97M | -9,40% |
| 2026-03-12 | Challenger LimitedSocietà | 1,13M | 9,01M | Acquisto | 7,97 | 16,39M | 7,40% |
| 2026-03-17 | Challenger LimitedSocietà | -1,39M | 12,76M | Vendita | 9,20 | 16,39M | -7,80% |
| 2026-03-20 | Challenger LimitedSocietà | -452,00k | 4,06M | Other Disposition | 8,98 | 16,39M | -2,68% |
| 2026-03-31 | Citigroup Inc.Società | -4,51M | 0,00 | Other Disposition | - | 11,33M | -28,45% |
| 2026-03-29 | Mr. Darren SmithGroup CFO | 1,11k | 0,00 | Derivative Exercise and Retained Stock | - | 11,92k | 10,28% |
| 2026-03-18 | Citigroup Inc.Società | -655,34k | 0,00 | Other Disposition | - | 15,84M | -3,97% |
| 2026-03-16 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | -20,05k | 0,00 | Other Derivative Disposition | - | - | - |
| 2026-03-03 | Challenger LimitedSocietà | 1,15M | 9,03M | Acquisto | 7,82 | 17,10M | 7,24% |
| 2026-01-27 | Challenger LimitedSocietà | -158,60k | 1,13M | Vendita | 7,15 | 17,10M | -0,92% |
| 2026-03-05 | Challenger LimitedSocietà | -324,74k | 2,29M | Other Disposition | 7,05 | 17,10M | -1,86% |
| 2026-01-30 | State Street Global Advisors, Inc.Società | -63,15M | 426,84k | Other Disposition | 6,38 - 7,83 | 33,34M | -65,45% |
| 2026-02-05 | JPMorgan Chase & Co.Società | -533,03k | 0,00 | Other Disposition | - | 9,14M | -5,51% |
| 2026-02-05 | JPMorgan Chase & Co.Società | -267,30k | 1,82M | Vendita | 5,88 - 7,34 | 9,14M | -2,84% |
| 2026-02-05 | JPMorgan Chase & Co.Società | 846,94k | 5,33M | Acquisto | 5,91 - 7,27 | 9,14M | 10,21% |
| 2026-02-05 | JPMorgan Chase & Co.Società | -2,21M | 9,89k | Other Disposition | 7,01 | 16,63M | -11,72% |
| 2026-01-22 | JPMorgan Chase & Co.Società | -1,37M | 0,00 | Other Disposition | - | 7,51M | -15,40% |
| 2026-01-22 | JPMorgan Chase & Co.Società | -591,28k | 4,65M | Vendita | 7,05 - 8,29 | 7,51M | -7,30% |
| 2026-01-22 | JPMorgan Chase & Co.Società | 904,80k | 7,05M | Acquisto | 7,00 - 8,31 | 7,51M | 13,70% |
| 2026-01-22 | JPMorgan Chase & Co.Società | -3,13M | 0,00 | Other Disposition | - | 14,59M | -17,65% |
| 2026-01-28 | JP Morgan Asset ManagementSocietà | -17,72 | 0,00 | Other Disposition | - | 322,23k | -0,01% |
| 2025-10-07 | State Street Global Advisors, Inc.Società | -152,49M | 22,40k | Other Disposition | 7,87 - 11,86 | 28,18M | -84,40% |
| 2026-01-21 | JPMorgan Chase & Co.Società | -344,44k | 2,05M | Other Disposition | 7,17 - 7,77 | 7,30M | -4,50% |
| 2026-01-21 | JPMorgan Chase & Co.Società | 544,35k | 3,98M | Acquisto | 7,12 - 7,51 | 7,30M | 8,05% |
| 2026-01-21 | JPMorgan Chase & Co.Società | -10,09k | 0,00 | Other Disposition | - | 11,13M | -0,09% |
| 2026-01-21 | JPMorgan Chase & Co.Società | -1,14k | 8,22k | Vendita | 7,22 | 7,30M | -0,02% |
| 2025-09-24 | Challenger LimitedSocietà | -7,35M | 64,48M | Vendita | 8,78 | 16,26M | -31,11% |
| 2025-09-24 | Challenger LimitedSocietà | 5,51M | 55,76M | Acquisto | 10,11 | 16,26M | 51,28% |
| 2025-11-13 | JPMorgan Chase & Co.Società | -2,05M | 0,00 | Other Disposition | - | 7,16M | -22,28% |
| 2025-11-13 | JPMorgan Chase & Co.Società | -4,97M | 42,48M | Vendita | 7,37 - 10,34 | 7,16M | -40,95% |
| 2025-11-13 | JPMorgan Chase & Co.Società | 2,90M | 25,29M | Acquisto | 7,37 - 10,34 | 7,16M | 68,11% |
| 2025-11-13 | JPMorgan Chase & Co.Società | -9,17M | 3,70k | Other Disposition | 7,80 | 9,13M | -50,10% |
| 2025-12-03 | JP Morgan Asset ManagementSocietà | -30,27k | 244,69k | Vendita | 7,82 - 9,62 | 323,45k | -8,56% |
| 2026-01-20 | JPMorgan Chase & Co.Società | 474,00 | 3,64k | Acquisto | 7,69 | 9,13M | 0,01% |
| 2025-07-16 | JP Morgan Asset ManagementSocietà | 3,71k | 58,33k | Acquisto | 15,72 | 353,70k | 1,06% |
| 2025-07-15 | JP Morgan Asset ManagementSocietà | -237,82k | 2,19M | Vendita | 9,04 - 15,58 | 353,70k | -40,21% |
| 2025-07-14 | JPMorgan Chase & Co.Società | -12,82M | 0,00 | Other Disposition | - | 8,62M | -59,80% |
| 2025-07-14 | JPMorgan Chase & Co.Società | 10,12M | 110,51M | Acquisto | 8,85 - 16,59 | 8,69M | -708,91% |
| 2025-07-14 | JPMorgan Chase & Co.Società | -8,18M | 89,20M | Vendita | 8,82 - 16,59 | 8,69M | -48,46% |
| 2025-07-15 | JPMorgan Chase & Co.Società | -7,02M | 0,00 | Other Disposition | - | 8,69M | -44,67% |
| 2025-11-05 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 100,71k | 286,60k | Derivative Exercise and Retained Stock | 2,85 | 21,33M | 0,47% |
| 2025-04-01 | State Street Global Advisors, Inc.Società | -89,40M | 0,00 | Other Disposition | 9,00 - 19,40 | 24,73M | -78,33% |
| 2025-09-16 | Challenger LimitedSocietà | 1,68M | 18,00M | Acquisto | 10,74 | 18,10M | 10,21% |
| 2025-09-16 | Challenger LimitedSocietà | -101,00k | 1,03M | Vendita | 10,24 | 18,10M | -0,56% |
| 2025-09-23 | Challenger LimitedSocietà | -299,38k | 3,24M | Other Disposition | 10,81 | 18,10M | -1,63% |
| 2025-09-09 | Challenger LimitedSocietà | 318,74k | 2,95M | Acquisto | 9,26 | 16,82M | 1,93% |
| 2025-09-09 | Challenger LimitedSocietà | -425,00k | 3,91M | Vendita | 9,21 | 16,82M | -2,46% |
| 2025-08-29 | Challenger LimitedSocietà | -238,09k | 2,27M | Other Disposition | 9,55 | 16,93M | -1,39% |
| 2025-08-22 | Challenger LimitedSocietà | 248,01k | 2,96M | Acquisto | 11,93 | 16,73M | 1,51% |
| 2025-08-28 | Challenger LimitedSocietà | -484,95k | 4,68M | Vendita | 9,65 | 16,73M | -2,82% |
| 2025-08-21 | Challenger LimitedSocietà | -348,41k | 4,05M | Other Disposition | 11,62 | 16,73M | -2,04% |
| 2025-04-23 | Challenger LimitedSocietà | 5,59M | 85,31M | Acquisto | 15,26 | 17,31M | 47,69% |
| 2025-05-12 | Challenger LimitedSocietà | -2,06M | 28,57M | Vendita | 13,90 | 17,31M | -10,61% |
| 2025-04-08 | Challenger LimitedSocietà | -469,95k | 7,18M | Other Disposition | 15,27 | 17,31M | -2,64% |
| 2025-06-13 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 2,60k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-06-13 | Dr. Christian P. BehrenbruchCo-Founder, MD, Group CEO & Executive Director | 166,48k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 18,66 | - | - |